Growing evidence suggests that CS birth may alter the gut microbiota (i.e. dysbiosis), increasing the risk of immune and metabolic disorders. This study aims to investigate the causal relationship between caesarean section (CS)-induced gut dysbiosis and obesity in a high-fat diet mouse model. In ...
Natural products from microorganisms are important sources for drug discovery. With the development of high-throughput sequencing technology and bioinformatics, a large amount of uncharacterized biosynthetic gene clusters (BGCs) in microorganisms have been found, which show the potential for nove...
OBJECTIVES: We investigated the effects of gut microbiota and serum metabolic levels on the patients with Budd-Chiari syndrome (B-CS), and their guidance for clinical management strategies.
DESIGN: 214 B-CS subjects including untreated case (n=93) and treat...